HIPEC consultation hour

Selected malignant tumors, which already have grown over the peritoneum (peritoneal carcinomatosis), can be completely removed by surgery and simultaneously treated by giving a chemotherapy in the abdomen during the operation. This new combination of surgery and chemotherapy can also be an option for patients with progressed tumors with peritoneal carcinomatosis.

This special method of directly giving chemotherapy into the abdomen is known as hyperthermic intraperitoneal chemotherapy (HIPEC). The advantage of HIPEC is that the chemotherapy works directly at the tumor and its close surrounding and is therefore more effective. Moreover, the chemotherapy is heated up to 42-43 degree Celsius, which is more effective when attacking the tumor cells and furthermore makes the tumor cells more sensitive for chemotherapy. The therapy's aim is to kill all tumor cells, even those that cannot be seen with the unaided eye.

The quality of the medical intervention is determined by pre-surgery diagnostics by identifying patients for which a complete tumor cell removal is possible and this treatment seems beneficial. For patients with a progressed peritoneal carcinomatosis a systematic chemotherapy can be a further treatment option after cytoreduction and HIPEC.

Contact:

You can reach our central entry port team as follows:

+49 (0) 40 7410 - 55692 ucch@uke.de

Head of the consultation hour:

Dr. med. Faik G. Uzunoglu